About Claris Injectables
Claris Injectables is a company based in Ahmedabad (India) founded in 2005 was acquired by Baxter in July 2017. The company has 66 employees as of April 08, 2024.
- Headquarter Ahmedabad, India
- Employees 66 as on 08 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Claris Limited
- Jurisdiction Ellisbridge, Gujarat, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Claris Injectables
Detailed funding history for Claris Injectables
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Claris Injectables
Claris Injectables has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Baxter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biosciences, medication delivery, and renal products are developed and marketed.
|
Locked | Locked | Locked |
Investor details for Claris Injectables
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Claris Injectables
Investment portfolio details for Claris Injectables
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Claris Injectables
Detailed financials for Claris Injectables
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Claris Injectables Comparisons
Peer comparison for Claris Injectables
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Claris Injectables
Detailed competitors of Claris Injectables
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Claris Injectables
Complete news archive for Claris Injectables
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Claris Injectables
Claris Injectables was founded in 2005.
Claris Injectables is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
As of Apr 08, 2024, the latest employee count at Claris Injectables is 66.
Annual revenue of Claris Injectables is $7.51M as on Mar 31, 2023.
Claris Injectables was founded in 2005 and is headquartered in Ahmedabad, India. Natural resource and energy projects in South Eastern Europe are developed through acquisition, exploration, and exploitation of sector opportunities. Gold and base metal properties are examined for potential, while additional acquisitions are pursued. Operations are conducted in compliance with environmental regulations, targeting sustainable practices in the sector.
Claris Injectables has 1 investor. Key investors include Baxter.